<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-25161" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Milk-Alkali Syndrome</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Rout</surname>
            <given-names>Preeti</given-names>
          </name>
          <aff>Wilson Case Western University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Hashmi</surname>
            <given-names>Muhammad F.</given-names>
          </name>
          <aff>National Health Service</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Patel</surname>
            <given-names>Chinmay</given-names>
          </name>
          <aff>Pikeville Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Preeti Rout declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Muhammad Hashmi declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Chinmay Patel declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>7</day>
          <month>6</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-25161.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Milk-alkali syndrome manifests through&#x000a0;the&#x000a0;triad of symptoms of elevated calcium levels, metabolic alkalosis, and acute kidney injury. Historically associated with the consumption of large quantities of milk and bicarbonate for peptic ulcer treatment, the syndrome is now predominantly triggered by excessive intake of calcium carbonate, particularly among osteoporosis patients or those with chronic kidney disease. Recent reports indicate a rising incidence, likely due to the widespread use of over-the-counter calcium supplements, particularly in older adults. Without intervention, the syndrome can rapidly progress to acute renal failure and metastatic calcification, potentially resulting in irreversible organ damage, especially in cases where the syndrome remains undetected or untreated over time.</p>
        <p>This activity equips learners with evidence-based strategies for managing milk-alkali syndrome, emphasizing the importance of individualized treatment plans tailored to each patient's unique needs and circumstances. By collaborating with interprofessional colleagues, participants learn to integrate pharmacological interventions, dietary modifications, and supportive care measures to optimize patient outcomes and mitigate the risk of complications such as acute renal failure and metabolic disturbances. Additionally, through ongoing dialogue and knowledge exchange within the interdisciplinary team, clinicians enhance their critical thinking skills and expand their interprofessional competence, ultimately fostering a collaborative approach to patient care that prioritizes holistic assessment, patient-centered interventions, and continuous quality improvement.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the symptoms and risk factors associated with milk-alkali syndrome, including hypercalcemia, metabolic alkalosis, and acute kidney injury.</p></list-item><list-item><p>Differentiate milk-alkali syndrome from other causes of hypercalcemia and metabolic alkalosis</p></list-item><list-item><p>Implement appropriate treatment protocols promptly to address hypercalcemia and prevent acute kidney injury.</p></list-item><list-item><p>Collaborate and communicate closely with an interprofessional team of nephrologists, endocrinologists, pharmacists, nurses, and dietitians to develop comprehensive treatment strategies tailored to the individual needs of patients with milk-alkali syndrome.&#x000a0;</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=25161&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=25161">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-25161.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Milk-alkali syndrome&#x000a0;is characterized&#x000a0;by a triad of elevated calcium levels, metabolic alkalosis, and acute kidney injury that commonly occurs due to the combined intake of large amounts of calcium and absorbable alkali. The syndrome can have an acute onset with the rapid development of hypercalcemia and, if left untreated, may cause acute renal failure and metastatic calcification.&#x000a0;The milk-alkali syndrome was first recognized in the early 20th century when Bertram Sippy introduced a treatment regimen for peptic ulcer disease.<xref ref-type="bibr" rid="article-25161.r1">[1]</xref>&#x000a0;The 'Sippy regimen' consisted of multiple daily doses of milk and cream combined with an absorbable alkali such as magnesium oxide, sodium bicarbonate, or bismuth subcarbonate to protect the gastric ulcer from further erosion by gastric acid. The results were highly favorable, and it soon became a popular therapy. Soon after, various toxic effects were reported, including hypercalcemia and metabolic alkalosis, and some cases of acute kidney injury&#x000a0;were also reported. With the advent of newer drugs for treating peptic ulcer disease, such as histamine type-2 receptor blockers, in the 1980s, the syndrome virtually vanished from the world.<xref ref-type="bibr" rid="article-25161.r2">[2]</xref></p>
        <p>Recently, however,&#x000a0;more&#x000a0;cases of milk-alkali syndrome have been reported.&#x000a0;This&#x000a0;is likely due to the&#x000a0;common&#x000a0;use of over-the-counter calcium preparations for preventing and treating osteoporosis in&#x000a0;women who are postmenopausal. Calcium carbonate is also frequently prescribed to patients with chronic kidney disease to prevent secondary hyperparathyroidism. Various scholars have also suggested changing the syndrome's name to calcium-alkali syndrome due to the changing etiopathology.<xref ref-type="bibr" rid="article-25161.r3">[3]</xref>&#x000a0;Milk-alkali syndrome now accounts for more than 10% of the cases of hypercalcemia and is the third most common cause of hypercalcemia in hospitalized patients (after hyperparathyroidism and hypercalcemia of malignancy).<xref ref-type="bibr" rid="article-25161.r4">[4]</xref></p>
      </sec>
      <sec id="article-25161.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Milk-alkali syndrome occurs primarily due to ingesting inappropriately high amounts of calcium carbonate. Increased awareness of the importance of calcium intake and the availability of over-the-counter calcium carbonate preparations for the treatment of osteoporosis and dyspepsia is the most common cause of&#x000a0;the milk-alkali&#x000a0;syndrome.<xref ref-type="bibr" rid="article-25161.r4">[4]</xref><xref ref-type="bibr" rid="article-25161.r5">[5]</xref>&#x000a0;Calcium supplements are also frequently prescribed to patients with chronic kidney disease (to prevent the development of secondary hyperparathyroidism) and patients on treatment regimens that may lead to bone loss,&#x000a0;eg, prolonged corticosteroid treatment. Usually, patients with milk-alkali syndrome consume calcium products containing more than 4&#x000a0;g/day of calcium; however, the syndrome has&#x000a0;been seen&#x000a0;in patients consuming as little as 1.0 g/day.<xref ref-type="bibr" rid="article-25161.r6">[6]</xref>&#x000a0;Ingestion of milk products or milk and bicarbonate&#x000a0;is no longer considered&#x000a0;a significant cause of this syndrome.</p>
        <p>Certain other drugs may also contribute to the development of this syndrome. An association between milk-alkali syndrome and thiazide diuretics has been reported.<xref ref-type="bibr" rid="article-25161.r7">[7]</xref>&#x000a0;Thiazide diuretics increase calcium reabsorption from the kidney, resulting in contraction alkalosis from volume depletion. Angiotensin-converting enzyme inhibitors and non-steroidal anti-inflammatory drugs also decrease renal calcium excretion by decreasing glomerular filtration rate (GFR).<xref ref-type="bibr" rid="article-25161.r4">[4]</xref>&#x000a0;Severe cases of milk-alkali syndrome have been reported in women who are pregnant.<xref ref-type="bibr" rid="article-25161.r8">[8]</xref>&#x000a0;Increased gastrointestinal absorption of calcium and amounts of parathyroid-related peptides in pregnant women are thought to play a role. Calcium carbonate is also commonly used for symptoms of reflux in pregnancy.&#x000a0;A rare cause is the use of large amounts of nicotine-substitute chewing gum, which may deliver high quantities of calcium.<xref ref-type="bibr" rid="article-25161.r9">[9]</xref>&#x000a0;The syndrome has occasionally also been described in betel nut chewers in India and Southeast Asia. The lime paste mixed with the nut's meat&#x000a0;contains high calcium carbonate. Heavy consumption has&#x000a0;been reported&#x000a0;to give rise to the milk-alkali syndrome.<xref ref-type="bibr" rid="article-25161.r10">[10]</xref></p>
      </sec>
      <sec id="article-25161.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Milk-alkali syndrome is a frequent cause of hypercalcemia in the United States. Results from a study on patients hospitalized for hypercalcemia showed that 12% of the cases were due to milk-alkali syndrome, making it the third most common cause after hyperparathyroidism and malignancy. Internationally, the frequency of the condition depends on the amount of calcium carbonate intake. Increased incidence of milk-alkali has&#x000a0;been reported&#x000a0;in places where betel nut chewing is&#x000a0;common, such as India and Southeast Asia.<xref ref-type="bibr" rid="article-25161.r10">[10]</xref>&#x000a0;Previously, when the etiology of the syndrome was the consumption of milk and absorbable alkali to treat peptic ulcer disease, more cases were reported in males. Currently, most of the cases are women who are post-menopausal due to their increased consumption of calcium carbonate products.<xref ref-type="bibr" rid="article-25161.r4">[4]</xref></p>
      </sec>
      <sec id="article-25161.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>An established prerequisite for developing this syndrome is the co-ingestion of large amounts of calcium and absorbable alkali.&#x000a0;Increased calcium absorption&#x000a0;from the small intestine, an effect strongly influenced by calcitriol levels, plays an important role.&#x000a0;In addition, increased vitamin D intake (often added to calcium supplements) may contribute to the development or worsening of the condition.</p>
        <p>Hypercalcemia has various effects on the kidney, eventually resulting in hypovolemia. This condition decreases the GFR by causing vasoconstriction and natriuresis by indirectly inhibiting the sodium, potassium, and&#x000a0;chloride (Na-K-2Cl) channels in the medullary thick ascending limb of the nephron.&#x000a0;Hypovolemia also decreases water reabsorption by inhibiting the antidiuretic hormone receptors (V2 receptors) in the basolateral membrane of collecting tubules in the kidney.</p>
        <p>The resultant hypovolemia contributes to the development of alkalosis by increasing bicarbonate reabsorption.<xref ref-type="bibr" rid="article-25161.r11">[11]</xref>&#x000a0;Alkalosis is a net result of increased alkali intake, hypercalcemia-mediated hypovolemia, and decreased GFR. Alkalosis&#x000a0;leads to increased&#x000a0;calcium reabsorption from the nephron&#x02019;s distal tubule, leading to hypercalcemia.<xref ref-type="bibr" rid="article-25161.r4">[4]</xref>&#x000a0;A vicious cycle develops due to hypercalcemia, alkalosis, and kidney injury.</p>
        <p>Certain factors worsen the situation further by increasing calcium levels or causing hypovolemia. These include taking drugs such as thiazide diuretics that decrease calcium excretion and cause natriuresis and vitamin D, increasing calcium absorption from the gut. Older individuals are at a higher risk of developing hypercalcemia and subsequent alkalosis following the intake of calcium supplements due to decreased bone buffering of the excess calcium.<xref ref-type="bibr" rid="article-25161.r4">[4]</xref>&#x000a0;Increased calcitriol levels in pregnancy may also contribute to hypercalcemia and the potential worsening of the syndrome if it develops.<xref ref-type="bibr" rid="article-25161.r12">[12]</xref></p>
      </sec>
      <sec id="article-25161.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Milk-alkali syndrome is a diagnosis of exclusion, and all other conditions causing hypercalcemia need to&#x000a0;be excluded. Careful history-taking and a detailed physical examination are vital. Currently, it is essential to gain information regarding drug intake, as various over-the-counter preparations contain calcium.<xref ref-type="bibr" rid="article-25161.r13">[13]</xref>&#x000a0;Most patients are asymptomatic; elevated levels of calcium, alkalosis, and renal damage&#x000a0;are incidentally discovered. However, some patients may present with acute or chronic signs and symptoms of hypercalcemia. Neurological symptoms of hypercalcemia include altered mental status, headache, vertigo, dizziness, and malaise. Gastrointestinal symptoms include nausea, vomiting, anorexia, and constipation. Genitourinary manifestations include increased urinary frequency and nephrolithiasis. Occasionally, patients may also experience palpitations.</p>
        <p>On physical exam, hypercalcemia can cause hyporeflexia of the deep tendon reflexes. Decreased muscle strength and tone may also be present. Depression, anxiety, or cognitive impairment may also&#x000a0;be noted&#x000a0;on psychiatric exams related to hypercalcemia. Metabolic alkalosis can also cause decreased minute ventilation and central respiratory drive, but this effect may be minimal.<xref ref-type="bibr" rid="article-25161.r14">[14]</xref><xref ref-type="bibr" rid="article-25161.r15">[15]</xref>&#x000a0;Historically,&#x000a0;3&#x000a0;progressive phases of the syndrome&#x000a0;were described&#x000a0;when the syndrome developed after the acute or prolonged use of the antacid regimen. Patients presented in the acute, subacute, and chronic stages depending on the duration and time since the exposure.</p>
        <p>
<bold>Acute Toxemic Phase</bold>
</p>
        <p>Patients usually present within a month of treatment with the antacid regimen. Symptoms of acute hypercalcemia, including headache, vertigo, dizziness, nausea, vomiting, and anorexia, were reported.</p>
        <p>
<bold>Subacute Phase (Cope syndrome)</bold>
</p>
        <p>Patients present with features of acute and chronic hypercalcemia.<xref ref-type="bibr" rid="article-25161.r16">[16]</xref></p>
        <p>
<bold>Chronic Phase (Brunett syndrome)</bold>
</p>
        <p>Patients treated with the milk and alkali regimen for years generally&#x000a0;demonstrated features of chronic hypercalcemia. Symptoms include polyuria, polydipsia, pruritis, tremors, and psychosis.&#x000a0;Abnormal calcium deposition in the tissues and organs&#x000a0;could&#x000a0;be observed&#x000a0;in the chronic phase.&#x000a0;Band keratopathy and nephrocalcinosis are commonly present. Metastatic calcification in other areas, including the liver, central nervous system, periarticular tissue, subcutaneous tissue, adrenals, bones, and lungs, is also frequently noted.<xref ref-type="bibr" rid="article-25161.r17">[17]</xref><xref ref-type="bibr" rid="article-25161.r18">[18]</xref></p>
      </sec>
      <sec id="article-25161.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Elevated serum calcium levels are usually an incidental discovery. Arterial blood gas analysis reveals metabolic alkalosis. Serum albumin levels should&#x000a0;be checked&#x000a0;in all patients with hypercalcemia, and corrected calcium levels must&#x000a0;be calculated&#x000a0;in patients with hypoalbuminemia. Ionized calcium levels can also&#x000a0;be considered&#x000a0;to avoid confounding values from hypoalbuminemia. With hypercalcemia, the next step in diagnosis is measuring serum parathyroid hormone levels, which are low in patients with the milk-alkali syndrome.<xref ref-type="bibr" rid="article-25161.r19">[19]</xref><xref ref-type="bibr" rid="article-25161.r20">[20]</xref>&#x000a0;This finding excludes primary hyperparathyroidism and familial hypocalciuric hypercalcemia during diagnostic evaluation. Serum phosphorus levels are low due to low parathyroid hormone levels but have&#x000a0;been reported&#x000a0;to be high in the classic syndrome due to high&#x000a0;quantities of&#x000a0;milk intake. Serum magnesium levels are usually low as hypercalcemia inhibits its reabsorption in the renal tubules; however, renal failure can cause hypermagnesemia due to the inability to secrete magnesium, so this should&#x000a0;be considered.<xref ref-type="bibr" rid="article-25161.r19">[19]</xref>&#x000a0;Blood urea nitrogen and creatinine can indicate the severity of renal damage.</p>
        <p>Various other tests can&#x000a0;be done&#x000a0;to exclude other causes of hypercalcemia, particularly with low serum parathyroid hormone levels. For example, thyroid-stimulating hormone (TSH) and free thyroxine levels can&#x000a0;be measured&#x000a0;to eliminate hyperthyroidism as a cause of hypercalcemia, and serum&#x000a0;protein or urine protein electrophoresis can help exclude multiple myeloma.&#x000a0;In addition, normal serum parathyroid-related peptide levels can help exclude malignancy, and normal 1,25 hydroxyvitamin D levels decrease the likelihood of sarcoidosis, which is a common cause&#x000a0;of hypercalcemia.</p>
        <p>Radiological investigations include chest x-rays, which can help exclude malignancy and sarcoidosis. Renal imaging may also&#x000a0;be warranted&#x000a0;in the case of renal dysfunction. The electrocardiogram in hypercalcemic patients may show QT interval shortening or ventricular arrhythmias.<xref ref-type="bibr" rid="article-25161.r21">[21]</xref>&#x000a0;Another frequent abnormality on ECG is the presence of J (Osborn) waves.<xref ref-type="bibr" rid="article-25161.r22">[22]</xref></p>
      </sec>
      <sec id="article-25161.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>For mild hypercalcemia, the only intervention needed is to withdraw the offending agent, which in most situations is calcium carbonate. As the source&#x000a0;is removed, hypercalcemia and alkalosis&#x000a0;are rapidly corrected&#x000a0;in milk-alkali syndrome. Severe hypercalcemia&#x000a0;is managed&#x000a0;in the hospital setting. Patients&#x000a0;are admitted, and the calcium supplement&#x000a0;is discontinued. Intravenous fluids such as normal saline&#x000a0;are started&#x000a0;to correct hypovolemia and to treat hypercalcemia.<xref ref-type="bibr" rid="article-25161.r23">[23]</xref>&#x000a0;The initial infusion rate is generally agreed to be 200 to 300 mL/h in those who are non-edematous and then adjusted to maintain a urine output of 100 to 150 mL/h. The rate, however, is highly variable and needs to be calculated according to the patient&#x02019;s age, renal status, co-morbid diseases, and the severity of hypercalcemia.</p>
        <p>Loop diuretics, like furosemide, can increase urinary calcium excretion. In severe cases of hypercalcemia, they can be started after the intravenous saline infusion&#x000a0;is begun&#x000a0;and should be continued with caution, as hypovolemia can worsen the hypercalcemia. Some patients develop mild&#x000a0;hypocalcemia&#x000a0;with a rebound rise in parathyroid hormone levels with loop diuretic treatment.<xref ref-type="bibr" rid="article-25161.r24">[24]</xref>&#x000a0;Hypocalcemia&#x000a0;is transient and generally does not need to be treated, but oral calcium citrate may&#x000a0;be considered. Calcium carbonate should&#x000a0;be avoided. Bisphosphonates should generally be avoided in patients with milk-alkali syndrome as they can cause prolonged&#x000a0;hypocalcemia.<xref ref-type="bibr" rid="article-25161.r19">[19]</xref>&#x000a0;Pamidronate, however, has been used with satisfactory results.</p>
      </sec>
      <sec id="article-25161.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>As stated previously, the milk-alkali syndrome is a diagnosis of exclusion. Multiple diseases and conditions result in hypercalcemia and need to be considered when diagnosing a suspected case of milk-alkali syndrome.</p>
        <p>Diseases causing hypercalcemia and elevated parathyroid hormone levels include these conditions:</p>
        <list list-type="bullet">
          <list-item>
            <p>Hyperparathyroidism (primary or tertiary)</p>
          </list-item>
          <list-item>
            <p>Familial hypocalciuric hypercalcemia</p>
          </list-item>
          <list-item>
            <p>Acquired hypocalciuric hypercalcemia</p>
          </list-item>
        </list>
        <p>Diseases causing hypercalcemia with a normal level of parathyroid hormone, similar to the milk-alkali syndrome, include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Malignancy</p>
          </list-item>
          <list-item>
            <p>Hyperthyroidism&#x000a0;<xref ref-type="bibr" rid="article-25161.r25">[25]</xref></p>
          </list-item>
          <list-item>
            <p>Hematological malignancies</p>
          </list-item>
          <list-item>
            <p>Immobilization</p>
          </list-item>
          <list-item>
            <p>Hypophosphatasia</p>
          </list-item>
          <list-item>
            <p>Sarcoidosis and other granulomatous disorders&#x000a0;<xref ref-type="bibr" rid="article-25161.r26">[26]</xref></p>
          </list-item>
        </list>
        <p>Hypercalcemia associated with drug use or vitamin intake includes these:</p>
        <list list-type="bullet">
          <list-item>
            <p>Thiazide diuretics</p>
          </list-item>
          <list-item>
            <p>Lithium</p>
          </list-item>
          <list-item>
            <p>Vitamin D</p>
          </list-item>
          <list-item>
            <p>Vitamin A toxicity</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-25161.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The prognosis of milk-alkali syndrome is good, as it can easily be reversed by stopping the ingestion of calcium supplements and absorbable alkalis. The morbidity associated with the disease is highly dependent on the severity and duration of hypercalcemia. If recognized early and treated appropriately, the chances of the development of complications can be significantly reduced, and the prognosis is favorable. However, chronic milk-alkali syndrome can cause permanent damage from systemic calcification, underscoring the importance of early detection and treatment.<xref ref-type="bibr" rid="article-25161.r18">[18]</xref></p>
      </sec>
      <sec id="article-25161.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Long-term complications of milk-alkali syndrome are uncommon due to easy reversability of acute milk-alkali syndrome. Withdrawing the offending agent is usually curative. Some studies, however, have reported permanent renal damage, even after the discontinuation of the causative agent in the diet. Several case reports have noted patients with elevated creatinine levels (&#x0003e;1.5 mg/dL) and even renal failure in follow-up investigations.<xref ref-type="bibr" rid="article-25161.r18">[18]</xref>&#x000a0;</p>
        <p>Neurological impairment, including obtundation and coma, has been reported in patients with calcium levels greater than 15 mg/dL. Older age, patients with a history of chronic kidney disease, and patients on dialysis are at high risk of complications.&#x000a0;There have been reports of status-epilepticus secondary to hypercalcemia in patients with milk-alkali syndrome.<xref ref-type="bibr" rid="article-25161.r27">[27]</xref></p>
      </sec>
      <sec id="article-25161.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Increased awareness about the importance of calcium, easy availability, and frequent prescription of supplements have resulted in a rise in milk-alkali syndrome cases in the past few years.<xref ref-type="bibr" rid="article-25161.r28">[28]</xref>&#x000a0;Patients should be informed of the disorder's pathogenesis and the common symptoms of hypercalcemia. Patients should be mindful of the supplements they are taking and their ingredients. Frequently, patients unknowingly take calcium through multiple sources. The recommended supplement dose and potentially harmful doses should be formally discussed with patients. This is especially important for patients with chronic renal disease because the chances of developing potentially lethal hypercalcemia and metabolic alkalosis are higher. Patients diagnosed with early milk-alkali syndrome should also&#x000a0;be reassured about the reversibility and generally good prognosis of the syndrome with the discontinuation of the offending agent.</p>
      </sec>
      <sec id="article-25161.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>An increased number of cases of milk-alkali syndrome have&#x000a0;been reported&#x000a0;in the past decade. Clinicians should keep milk-alkali syndrome high on the differential when considering a patient presenting with hypercalcemia. Though generally asymptomatic and discovered incidentally, it can rapidly lead to the development of life-threatening hypercalcemia and alkalosis and may progress to renal failure if left untreated. Clinicians&#x000a0;need to&#x000a0;be well-versed in the causes, pathophysiology, complications, and management of hypercalcemia and alkalosis resulting from this disorder.&#x000a0;Being a reversible condition, early management can prove to be life-saving.</p>
        <p>An interprofessional team approach with effective communication between the members, including internists, endocrinologists, nephrologists, nurses, and pharmacists, is required to enhance patient care and improve outcomes. Nursing staff plays a crucial role in the case, assisting with patient assessment, counseling patients on their condition and treatment, and helping coordinate the activities of the various specialists and other clinicians. Pharmacists can counsel patients on medication taken to treat the disease and provide education regarding which medications may lead to milk-alkali syndrome. They also perform medication reconciliation to check for drug interactions. All care team members must maintain meticulous records and report any concerns or patient condition changes to other team members.&#x000a0;</p>
        <p>Care coordination is pivotal in ensuring seamless and efficient patient care. Physicians, advanced practitioners, nurses, pharmacists, and other healthcare professionals must work together to streamline the patient&#x02019;s journey, from diagnosis through treatment and follow-up. This coordination minimizes errors, reduces delays, and enhances patient safety, ultimately leading to improved outcomes and patient-centered care that prioritizes the well-being and satisfaction of those affected by milk-alkali syndrome.&#x000a0;This interprofessional approach with open communication will yield the best possible results.</p>
      </sec>
      <sec id="article-25161.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=25161&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=25161">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/health/milk-alkali-syndrome/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=25161">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/25161/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=25161">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-25161.s15">
        <title>References</title>
        <ref id="article-25161.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sippy</surname>
                <given-names>BW</given-names>
              </name>
            </person-group>
            <article-title>Landmark article May 15, 1915: Gastric and duodenal ulcer. Medical cure by an efficient removal of gastric juice corrosion. By Bertram W. Sippy.</article-title>
            <source>JAMA</source>
            <year>1983</year>
            <month>Oct</month>
            <day>28</day>
            <volume>250</volume>
            <issue>16</issue>
            <fpage>2192</fpage>
            <page-range>2192-7</page-range>
            <pub-id pub-id-type="pmid">6352976</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25161.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jamieson</surname>
                <given-names>MJ</given-names>
              </name>
            </person-group>
            <article-title>Hypercalcaemia.</article-title>
            <source>Br Med J (Clin Res Ed)</source>
            <year>1985</year>
            <month>Feb</month>
            <day>02</day>
            <volume>290</volume>
            <issue>6465</issue>
            <fpage>378</fpage>
            <page-range>378-82</page-range>
            <pub-id pub-id-type="pmid">3917827</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25161.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Patel</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Adeseun</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Goldfarb</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Calcium-alkali syndrome in the modern era.</article-title>
            <source>Nutrients</source>
            <year>2013</year>
            <month>Nov</month>
            <day>27</day>
            <volume>5</volume>
            <issue>12</issue>
            <fpage>4880</fpage>
            <page-range>4880-93</page-range>
            <pub-id pub-id-type="pmid">24288027</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25161.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Patel</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Goldfarb</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Got calcium? Welcome to the calcium-alkali syndrome.</article-title>
            <source>J Am Soc Nephrol</source>
            <year>2010</year>
            <month>Sep</month>
            <volume>21</volume>
            <issue>9</issue>
            <fpage>1440</fpage>
            <page-range>1440-3</page-range>
            <pub-id pub-id-type="pmid">20413609</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25161.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yang</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Lawson</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Beland</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Severe hypercalcemia from the milk-alkali syndrome.</article-title>
            <source>Am J Med</source>
            <year>2013</year>
            <month>Sep</month>
            <volume>126</volume>
            <issue>9</issue>
            <fpage>e1</fpage>
            <page-range>e1-2</page-range>
            <pub-id pub-id-type="pmid">23830540</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25161.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>He</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Morton</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Milk-alkali syndrome.</article-title>
            <source>Aust J Gen Pract</source>
            <year>2024</year>
            <month>Apr</month>
            <volume>53</volume>
            <issue>4</issue>
            <fpage>187</fpage>
            <page-range>187-188</page-range>
            <pub-id pub-id-type="pmid">38575533</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25161.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Parvez</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Emuwa</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Faulkner</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Murray</surname>
                <given-names>JJ</given-names>
              </name>
            </person-group>
            <article-title>Milk alkali and hydrochlorothiazide: a case report.</article-title>
            <source>Case Rep Med</source>
            <year>2011</year>
            <volume>2011</volume>
            <fpage>729862</fpage>
            <pub-id pub-id-type="pmid">21738535</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25161.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Addington</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Larson</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Scofield</surname>
                <given-names>RH</given-names>
              </name>
            </person-group>
            <article-title>Milk-alkali syndrome in pre-eclamptic pregnancy: report of a patient and evaluation of albumin-corrected calcium in pre-eclamptic pregnancies.</article-title>
            <source>J Okla State Med Assoc</source>
            <year>2006</year>
            <month>Sep</month>
            <volume>99</volume>
            <issue>9</issue>
            <fpage>480</fpage>
            <page-range>480-4</page-range>
            <pub-id pub-id-type="pmid">17087071</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25161.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Swanson</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Mackey</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Westphal</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Argueta</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Nicotine-substitute gum-induced milk alkali syndrome: a look at unexpected sources of calcium.</article-title>
            <source>Endocr Pract</source>
            <year>2013</year>
            <season>Nov-Dec</season>
            <volume>19</volume>
            <issue>6</issue>
            <fpage>142</fpage>
            <page-range>142-4</page-range>
            <pub-id pub-id-type="pmid">23807522</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25161.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wu</surname>
                <given-names>KD</given-names>
              </name>
              <name>
                <surname>Chuang</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>FL</given-names>
              </name>
              <name>
                <surname>Hsu</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>Jan</surname>
                <given-names>IS</given-names>
              </name>
              <name>
                <surname>Tsai</surname>
                <given-names>KS</given-names>
              </name>
            </person-group>
            <article-title>The milk-alkali syndrome caused by betelnuts in oyster shell paste.</article-title>
            <source>J Toxicol Clin Toxicol</source>
            <year>1996</year>
            <volume>34</volume>
            <issue>6</issue>
            <fpage>741</fpage>
            <page-range>741-5</page-range>
            <pub-id pub-id-type="pmid">8941207</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25161.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>&#x0017d;ofkov&#x000e1;</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Hypercalcemia. Pathophysiological aspects.</article-title>
            <source>Physiol Res</source>
            <year>2016</year>
            <volume>65</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-10</page-range>
            <pub-id pub-id-type="pmid">26596315</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25161.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kolnick</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Harris</surname>
                <given-names>BD</given-names>
              </name>
              <name>
                <surname>Choma</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Choma</surname>
                <given-names>NN</given-names>
              </name>
            </person-group>
            <article-title>Hypercalcemia in pregnancy: a case of milk-alkali syndrome.</article-title>
            <source>J Gen Intern Med</source>
            <year>2011</year>
            <month>Aug</month>
            <volume>26</volume>
            <issue>8</issue>
            <fpage>939</fpage>
            <page-range>939-42</page-range>
            <pub-id pub-id-type="pmid">21347876</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25161.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Arroyo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fenves</surname>
                <given-names>AZ</given-names>
              </name>
              <name>
                <surname>Emmett</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>The calcium-alkali syndrome.</article-title>
            <source>Proc (Bayl Univ Med Cent)</source>
            <year>2013</year>
            <month>Apr</month>
            <volume>26</volume>
            <issue>2</issue>
            <fpage>179</fpage>
            <page-range>179-81</page-range>
            <pub-id pub-id-type="pmid">23543983</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25161.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Oppersma</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Doorduin</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>van der Hoeven</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Veltink</surname>
                <given-names>PH</given-names>
              </name>
              <name>
                <surname>van Hees</surname>
                <given-names>HWH</given-names>
              </name>
              <name>
                <surname>Heunks</surname>
                <given-names>LMA</given-names>
              </name>
            </person-group>
            <article-title>The effect of metabolic alkalosis on the ventilatory response in healthy subjects.</article-title>
            <source>Respir Physiol Neurobiol</source>
            <year>2018</year>
            <month>Feb</month>
            <volume>249</volume>
            <fpage>47</fpage>
            <page-range>47-53</page-range>
            <pub-id pub-id-type="pmid">29307724</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25161.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Broadman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Jensen</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Effect of induced acute metabolic alkalosis on the &#x00056;&#x00307;<sub>E</sub>/&#x00056;&#x00307;CO<sub>2</sub> response to exercise in healthy adults.</article-title>
            <source>Respir Physiol Neurobiol</source>
            <year>2021</year>
            <month>Dec</month>
            <volume>294</volume>
            <fpage>103740</fpage>
            <pub-id pub-id-type="pmid">34256173</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25161.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kallmeyer</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Funston</surname>
                <given-names>MR</given-names>
              </name>
            </person-group>
            <article-title>The milk-alkali syndrome. A case report.</article-title>
            <source>S Afr Med J</source>
            <year>1983</year>
            <month>Aug</month>
            <day>20</day>
            <volume>64</volume>
            <issue>8</issue>
            <fpage>287</fpage>
            <page-range>287-8</page-range>
            <pub-id pub-id-type="pmid">6688308</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25161.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>PUNSAR</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>SOMER</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>The milk-alkali syndrome. A report of three illustrative cases and a review of the literature.</article-title>
            <source>Acta Med Scand</source>
            <year>1963</year>
            <month>Apr</month>
            <volume>173</volume>
            <fpage>435</fpage>
            <page-range>435-49</page-range>
            <pub-id pub-id-type="pmid">13972538</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25161.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yamagami</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Nakamura</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kishida</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hanioka</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Nakamura</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Yamaguchi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Nishijima</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Inoue</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Yoshioka</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Imanishi</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Pulmonary and gastric metastatic calcification due to milk-alkali syndrome: a case report.</article-title>
            <source>CEN Case Rep</source>
            <year>2013</year>
            <month>Nov</month>
            <volume>2</volume>
            <issue>2</issue>
            <fpage>209</fpage>
            <page-range>209-214</page-range>
            <pub-id pub-id-type="pmid">28509300</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25161.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Picolos</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Lavis</surname>
                <given-names>VR</given-names>
              </name>
              <name>
                <surname>Orlander</surname>
                <given-names>PR</given-names>
              </name>
            </person-group>
            <article-title>Milk-alkali syndrome is a major cause of hypercalcaemia among non-end-stage renal disease (non-ESRD) inpatients.</article-title>
            <source>Clin Endocrinol (Oxf)</source>
            <year>2005</year>
            <month>Nov</month>
            <volume>63</volume>
            <issue>5</issue>
            <fpage>566</fpage>
            <page-range>566-76</page-range>
            <pub-id pub-id-type="pmid">16268810</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25161.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Medarov</surname>
                <given-names>BI</given-names>
              </name>
            </person-group>
            <article-title>Milk-alkali syndrome.</article-title>
            <source>Mayo Clin Proc</source>
            <year>2009</year>
            <month>Mar</month>
            <volume>84</volume>
            <issue>3</issue>
            <fpage>261</fpage>
            <page-range>261-7</page-range>
            <pub-id pub-id-type="pmid">19252114</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25161.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Miller</surname>
                <given-names>PD</given-names>
              </name>
            </person-group>
            <article-title>Vitamin D, calcium, and cardiovascular mortality: a perspective from a plenary lecture given at the annual meeting of the American Association of Clinical Endocrinologists.</article-title>
            <source>Endocr Pract</source>
            <year>2011</year>
            <season>Sep-Oct</season>
            <volume>17</volume>
            <issue>5</issue>
            <fpage>798</fpage>
            <page-range>798-806</page-range>
            <pub-id pub-id-type="pmid">21856593</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25161.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chhabra</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Spodick</surname>
                <given-names>DH</given-names>
              </name>
            </person-group>
            <article-title>Milk Alkali syndrome: an electrocardiographic masquerader for non-hypothermic Osborn phenomenon.</article-title>
            <source>Heart</source>
            <year>2013</year>
            <month>Sep</month>
            <volume>99</volume>
            <issue>17</issue>
            <fpage>1302</fpage>
            <page-range>1302-3</page-range>
            <pub-id pub-id-type="pmid">23680883</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25161.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Timilsina</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Tachamo</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Parajuli</surname>
                <given-names>PR</given-names>
              </name>
              <name>
                <surname>Gabriely</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Acute milk-alkali syndrome.</article-title>
            <source>Endocrinol Diabetes Metab Case Rep</source>
            <year>2018</year>
            <month>Oct</month>
            <day>31</day>
            <volume>2018</volume>
            <issue>1</issue>
            <pub-id pub-id-type="pmid">30422607</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25161.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Beall</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Scofield</surname>
                <given-names>RH</given-names>
              </name>
            </person-group>
            <article-title>Milk-alkali syndrome associated with calcium carbonate consumption. Report of 7 patients with parathyroid hormone levels and an estimate of prevalence among patients hospitalized with hypercalcemia.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>1995</year>
            <month>Mar</month>
            <volume>74</volume>
            <issue>2</issue>
            <fpage>89</fpage>
            <page-range>89-96</page-range>
            <pub-id pub-id-type="pmid">7891547</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25161.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Xie</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Mo</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <article-title>Hyperthyroidism-associated hypercalcemic crisis: A case report and review of the literature.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2017</year>
            <month>Jan</month>
            <volume>96</volume>
            <issue>4</issue>
            <fpage>e6017</fpage>
            <pub-id pub-id-type="pmid">28121960</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25161.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Baughman</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Janovcik</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ray</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sweiss</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Lower</surname>
                <given-names>EE</given-names>
              </name>
            </person-group>
            <article-title>&#x0feff;&#x0feff;Calcium and vitamin D metabolism in sarcoidosis.</article-title>
            <source>Sarcoidosis Vasc Diffuse Lung Dis</source>
            <year>2013</year>
            <month>Aug</month>
            <day>01</day>
            <volume>30</volume>
            <issue>2</issue>
            <fpage>113</fpage>
            <page-range>113-20</page-range>
            <pub-id pub-id-type="pmid">24071882</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25161.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kashouty</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Yono</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Al Samara</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Status epilepticus secondary to milk-alkali syndrome induced by hypercalcemia (oral antacids).</article-title>
            <source>Seizure</source>
            <year>2011</year>
            <month>Oct</month>
            <volume>20</volume>
            <issue>8</issue>
            <fpage>659</fpage>
            <page-range>659-61</page-range>
            <pub-id pub-id-type="pmid">21514851</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25161.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Beall</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Henslee</surname>
                <given-names>HB</given-names>
              </name>
              <name>
                <surname>Webb</surname>
                <given-names>HR</given-names>
              </name>
              <name>
                <surname>Scofield</surname>
                <given-names>RH</given-names>
              </name>
            </person-group>
            <article-title>Milk-alkali syndrome: a historical review and description of the modern version of the syndrome.</article-title>
            <source>Am J Med Sci</source>
            <year>2006</year>
            <month>May</month>
            <volume>331</volume>
            <issue>5</issue>
            <fpage>233</fpage>
            <page-range>233-42</page-range>
            <pub-id pub-id-type="pmid">16702792</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
